| Similar Articles |
|---|
 |
Bio-IT World
September 2006
Mark D. Uehling |
Spotfire: Seeing Your Clinical Trial Data Jump Spotfire's DecisionSite system offers a new window on clinical research.   |
Bio-IT World
November 19, 2004
John Russell |
Sourcebook: Matters of Interpretation Michael O'Connell talks about trends in microarray and mass-spec data analysis and Insightful Corp.'s recent deal with visualization specialist Spotfire. |
Bio-IT World
August 18, 2004 |
Project Summaries Drug Discovery and Development: Ace BioSciences... Compugen... Entelos/Organon... Iconix Pharmaceuticals... Johnson & Johnson Pharmaceutical Research & Development... Laboratoire Kastler Brossel ... etc. |
Pharmaceutical Executive
September 1, 2005
Mattingly & Saxberg |
Biomarkers Come of Age In the past five years, biomarkers have become an essential part of pharmaceutical R&D. Seven industry experts explain how it happened - and what comes next. |
Bio-IT World
March 8, 2005
Patricia Reilly |
Biomarkers: Trends and Potential Companies are centralizing biomarker research to help reduce spending. |
CIO
July 15, 2002
Christopher Lindquist |
Creative Visualizatio Spotfire analysis tools turn complex data into pretty -- and powerful -- pictures. |
IndustryWeek
September 1, 2004
John Teresko |
Too Much Data, Not Enough Info? Spotfire's Christopher Ahlberg, CEO and founder, says the core value of DecisionSite is its ability to use databases to drive decisions in real time. |
